Table 2.
Antimicrobial susceptibility testing determined using the E-test method
| Antimicrobial agent | Strain patient 1 | Strain patient 2 | ||
|---|---|---|---|---|
| MIC (µg/ml) | Clinical categorizationa | MIC (µg/ml) | Clinical categorizationa | |
| Amikacin | 0.38 | S | 1 | S |
| Amoxicillin-clavulanic acid | 6 | S | 6 | S |
| Ceftriaxone | 1.5 | S | 0.25 | S |
| Ciprofloxacin | 32 | R | 2 | I |
| Clarithromycin | 3 | R | 4 | R |
| Imipenem | 0.25 | S | 0.125 | S |
| Linezolid | 1.5 | S | 0.19 | S |
| Minocycline | 1 | S | 0.125 | S |
| Trimethoprim-sulfamethoxazole | 0.047 | S | 1 | S |
| Tobramycin | 0.75 | S | 3 | S |
aInterpretations of MICs in terms of susceptibility for Nocardia according to the criteria of CLSI [11].